1. Benjamin, L.J., L.R. Berkowitz, E. Orringer, V.N. Mankad, A.S. Prasad, L.M. Lewkow, R.K. Chillar and C.M. Peterson, 1986, A collaborative, double-blind randomized study of cetiedil citrate in sickle cell crisis, Blood 67, 1442.
2. Benton, D.C. and D.G. Haylett, 1992, Effects of cromakalim on the membrane potassium permeability of frog skeletal muscle in vitro, Br. J. Pharmacol. 107, 152.
3. Benton, D.C.H., S. Athmani, C.J. Roxburgh, M.A.R. Shiner, D.G. Haylett, C.R. Ganellin and D.H. Jenkinson, 1994, Effects of cetiedil and its analogues on the Ca2+-activated K+ permeability of rabbit erythrocytes and on levcromakalim-stimulated 86Rb efflux from rat aorta, Br. J. Pharmacol. 112, 466P.
4. Berkowitz, L.R. and E.P. Orringer, 1982, Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia, Blood Cells 8, 283.
5. Berry, J.L., R.C. Small and R.W. Foster, 1992a, Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents, Br. J. Pharmacol. 106, 813.